$78.00
CJC-1295 (No DAC) 10 mL Vial
The Science, Simplified: CJC-1295 (No DAC), also known as Modified GRF (1-29), is a short-acting synthetic tetrasubstituted analog of growth hormone-releasing hormone (GHRH) used as a GHRH-receptor research tool.
Product Specifications – CJC-1295 (No DAC) 10 mL Vial (10 mg)
Key Research Focus: Studied in laboratory GH-axis models examining pulsatile GHRH receptor activation without albumin-binding DAC extension effects.
Physical Form & Solubility:
Stability & Handling Notes:
CJC-1295 (No DAC) 10 mg / 10 mL (1 mg/mL) research vial from Palm Beach Vitality. Third-party tested; COA available upon request. Laboratory research use only.
How Labs Use This Format: Pipette at 1 mg/mL from this ready-to-use liquid vial for single-compound GHRH analog work. CJC/Ipamorelin blend pens or vials may be available when dual-pathway formats are preferred.
Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.
Looking for the long-acting version? See CJC-1295 (with DAC) 10mg Vial, same price and format.
COA available upon request. Free shipping on orders over $250. For laboratory research use only; not for human use.
Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.
Read the CJC-1295 research overview
Join the list for new compounds, research notes, and subscriber-only offers.
For more information on how we process your data for marketing communication. Check our Privacy policy.